{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:49:55Z","timestamp":1788569395860,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82350103"],"award-info":[{"award-number":["82350103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330005"],"award-info":[{"award-number":["82330005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open fund of Hubei Key Laboratory of Biological Targeted Therapy Research","award":["202302"],"award-info":[{"award-number":["202302"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00277-025-06338-6","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T12:33:58Z","timestamp":1744115638000},"page":"1887-1895","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The impact of obesity and its related underlying diseases on cytokine release syndrome and the efficacy of CAR-T therapy in treating B-cell malignancies"],"prefix":"10.1007","volume":"104","author":[{"given":"Mengyi","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna Tryphene Massounga","family":"Mayombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danying","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"issue":"5","key":"6338_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMoa1709866","volume":"378","author":"SL Maude","year":"2018","unstructured":"Maude SL, Laetsch TW, Buechner J, Rives S, Boyer M, Bittencourt H, Bader P, Verneris MR, Stefanski HE, Myers GD, Qayed M, De Moerloose B, Hiramatsu H, Schlis K, Davis KL, Martin PL, Nemecek ER, Yanik GA, Peters C, Baruchel A, Boissel N, Mechinaud F, Balduzzi A, Krueger J, June CH, Levine BL, Wood P, Taran T, Leung M, Mueller KT, Zhang Y, Sen K, Lebwohl D, Pulsipher MA, Grupp SA (2018) Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia. N Engl J Med 378(5):439\u2013448. https:\/\/doi.org\/10.1056\/NEJMoa1709866","journal-title":"N Engl J Med"},{"issue":"1","key":"6338_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1470-2045(18)30864-7","volume":"20","author":"FL Locke","year":"2019","unstructured":"Locke FL, Ghobadi A, Jacobson CA, Miklos DB, Lekakis LJ, Oluwole OO, Lin Y, Braunschweig I, Hill BT, Timmerman JM, Deol A, Reagan PM, Stiff P, Flinn IW, Farooq U, Goy A, McSweeney PA, Munoz J, Siddiqi T, Chavez JC, Herrera AF, Bartlett NL, Wiezorek JS, Navale L, Xue A, Jiang Y, Bot A, Rossi JM, Kim JJ, Go WY, Neelapu SS (2019) Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1\u20132 trial. Lancet Oncol 20(1):31\u201342. https:\/\/doi.org\/10.1016\/S1470-2045(18)30864-7","journal-title":"Lancet Oncol"},{"issue":"4","key":"6338_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ccell.2020.07.005","volume":"38","author":"M Hong","year":"2020","unstructured":"Hong M, Clubb JD, Chen YY (2020) Engineering CAR-T Cells for Next-Generation Cancer Therapy. Cancer Cell 38(4):473\u2013488. https:\/\/doi.org\/10.1016\/j.ccell.2020.07.005","journal-title":"Cancer Cell"},{"issue":"7709","key":"6338_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41586-018-0178-z","volume":"558","author":"JA Fraietta","year":"2018","unstructured":"Fraietta JA, Nobles CL, Sammons MA, Lundh S, Carty SA, Reich TJ, Cogdill AP, Morrissette JJD, DeNizio JE, Reddy S, Hwang Y, Gohil M, Kulikovskaya I, Nazimuddin F, Gupta M, Chen F, Everett JK, Alexander KA, Lin-Shiao E, Gee MH, Liu X, Young RM, Ambrose D, Wang Y, Xu J, Jordan MS, Marcucci KT, Levine BL, Garcia KC, Zhao Y, Kalos M, Porter DL, Kohli RM, Lacey SF, Berger SL, Bushman FD, June CH, Melenhorst JJ (2018) Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells. Nature 558(7709):307\u2013312. https:\/\/doi.org\/10.1038\/s41586-018-0178-z","journal-title":"Nature"},{"issue":"6382","key":"6338_CR5","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1126\/science.aar6711","volume":"359","author":"CH June","year":"2018","unstructured":"June CH, O\u2019Connor RS, Kawalekar OU, Ghassemi S, Milone MC (2018) CAR T cell immunotherapy for human cancer. Science 359(6382):1361\u20131365. https:\/\/doi.org\/10.1126\/science.aar6711","journal-title":"Science"},{"issue":"7897","key":"6338_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","volume":"602","author":"JJ Melenhorst","year":"2022","unstructured":"Melenhorst JJ, Chen GM, Wang M, Porter DL, Chen C, Collins MA, Gao P, Bandyopadhyay S, Sun H, Zhao Z, Lundh S, Pruteanu-Malinici I, Nobles CL, Maji S, Frey NV, Gill SI, Tian L, Kulikovskaya I, Gupta M, Ambrose DE, Davis MM, Fraietta JA, Brogdon JL, Young RM, Chew A, Levine BL, Siegel DL, Alanio C, Wherry EJ, Bushman FD, Lacey SF, Tan K, June CH (2022) Decade-long leukaemia remissions with persistence of CD4(+) CAR T cells. Nature 602(7897):503\u2013509. https:\/\/doi.org\/10.1038\/s41586-021-04390-6","journal-title":"Nature"},{"issue":"23","key":"6338_CR7","doi-asserted-by":"publisher","first-page":"6040","DOI":"10.1182\/bloodadvances.2022007676","volume":"6","author":"AJ Faruqi","year":"2022","unstructured":"Faruqi AJ, Ligon JA, Borgman P, Steinberg SM, Foley T, Little L, Mackall CL, Lee DW, Fry TJ, Shalabi H, Brudno J, Yates B, Mikkilineni L, Kochenderfer J, Shah NN (2022) The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes. Blood Adv 6(23):6040\u20136050. https:\/\/doi.org\/10.1182\/bloodadvances.2022007676","journal-title":"Blood Adv"},{"issue":"11","key":"6338_CR8","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.120.316101","volume":"126","author":"ME Piche","year":"2020","unstructured":"Piche ME, Tchernof A, Despres JP (2020) Obesity Phenotypes, Diabetes, and Cardiovascular Diseases. Circ Res 126(11):1477\u20131500. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316101","journal-title":"Circ Res"},{"issue":"7","key":"6338_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41408-021-00515-2","volume":"11","author":"K Wudhikarn","year":"2021","unstructured":"Wudhikarn K, Bansal R, Khurana A, Hathcock MA, Bennani NN, Paludo J, Villasboas JC, Wang Y, Johnston PB, Ansell SM, Lin Y (2021) The impact of obesity and body weight on the outcome of patients with relapsed\/refractory large B-cell lymphoma treated with axicabtagene ciloleucel. Blood Cancer J 11(7):124. https:\/\/doi.org\/10.1038\/s41408-021-00515-2","journal-title":"Blood Cancer J"},{"issue":"9","key":"6338_CR10","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.3324\/haematol.2021.280189","volume":"107","author":"DMC Dos Santos","year":"2022","unstructured":"Dos Santos DMC, Rejeski K, Winkelmann M, Liu L, Trinkner P, Gunther S, Bucklein VL, Blumenberg V, Schmidt C, Kunz WG, Von Bergwelt-Baildon M, Theurich S, Subklewe M (2022) Increased visceral fat distribution and body composition impact cytokine release syndrome onset and severity after CD19 chimeric antigen receptor T-cell therapy in advanced B-cell malignancies. Haematologica 107(9):2096\u20132107. https:\/\/doi.org\/10.3324\/haematol.2021.280189","journal-title":"Haematologica"},{"issue":"11","key":"6338_CR11","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1038\/s41375-022-01676-0","volume":"36","author":"P Jiang","year":"2022","unstructured":"Jiang P, Zhang Z, Hu Y, Liang Z, Han Y, Li X, Zeng X, Zhang H, Zhu M, Dong J, Huang H, Qian P (2022) Single-cell ATAC-seq maps the comprehensive and dynamic chromatin accessibility landscape of CAR-T cell dysfunction. Leukemia 36(11):2656\u20132668. https:\/\/doi.org\/10.1038\/s41375-022-01676-0","journal-title":"Leukemia"},{"issue":"4","key":"6338_CR12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","volume":"25","author":"DW Lee","year":"2019","unstructured":"Lee DW, Santomasso BD, Locke FL, Ghobadi A, Turtle CJ, Brudno JN, Maus MV, Park JH, Mead E, Pavletic S, Go WY, Eldjerou L, Gardner RA, Frey N, Curran KJ, Peggs K, Pasquini M, DiPersio JF, van den Brink MRM, Komanduri KV, Grupp SA, Neelapu SS (2019) ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells. Biol Blood Marrow Transplant\u202f: J Am Soc Blood Marrow Transplant 25(4):625\u2013638. https:\/\/doi.org\/10.1016\/j.bbmt.2018.12.758","journal-title":"Biol Blood Marrow Transplant : J Am Soc Blood Marrow Transplant"},{"key":"6338_CR13","doi-asserted-by":"publisher","unstructured":"Du M, Mayombo RT, Liu J, Zhang Y, Liao D, Hu Y, Mei H. The impact of obesity and its related underlying diseases on cytokine release syndrome and the efficacy of CAR-T therapy in treating B-cell malignancies 43(2):89 95https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2022.02.001","DOI":"10.3760\/cma.j.issn.0253-2727.2022.02.001"},{"issue":"11","key":"6338_CR14","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00011-009-0060-4","volume":"58","author":"K Eder","year":"2009","unstructured":"Eder K, Baffy N, Falus A, Fulop AK (2009) The major inflammatory mediator interleukin-6 and obesity. Inflamm Res 58(11):727\u2013736. https:\/\/doi.org\/10.1007\/s00011-009-0060-4","journal-title":"Inflamm Res"},{"issue":"5","key":"6338_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41577-019-0156-1","volume":"19","author":"A Christ","year":"2019","unstructured":"Christ A, Latz E (2019) The Western lifestyle has lasting effects on metaflammation. Nat Rev Immunol 19(5):267\u2013268. https:\/\/doi.org\/10.1038\/s41577-019-0156-1","journal-title":"Nat Rev Immunol"},{"key":"6338_CR16","doi-asserted-by":"publisher","unstructured":"Ferrante AW, Jr. (2013) The immune cells in adipose tissue. Diabetes Obes Metab 15 Suppl 3 (3):34\u201338. https:\/\/doi.org\/10.1111\/dom.12154","DOI":"10.1111\/dom.12154"},{"issue":"1","key":"6338_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41584-021-00713-z","volume":"18","author":"V Francisco","year":"2022","unstructured":"Francisco V, Pino J, Gonzalez-Gay MA, Lago F, Karppinen J, Tervonen O, Mobasheri A, Gualillo O (2022) A new immunometabolic perspective of intervertebral disc degeneration. Nat Rev Rheumatol 18(1):47\u201360. https:\/\/doi.org\/10.1038\/s41584-021-00713-z","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"6338_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI92035","volume":"127","author":"AR Saltiel","year":"2017","unstructured":"Saltiel AR, Olefsky JM (2017) Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest 127(1):1\u20134. https:\/\/doi.org\/10.1172\/JCI92035","journal-title":"J Clin Invest"},{"issue":"5","key":"6338_CR19","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.ymthe.2024.03.004","volume":"32","author":"J Nong","year":"2024","unstructured":"Nong J, Glassman PM, Shuvaev VV, Reyes-Esteves S, Descamps HC, Kiseleva RY, Papp TE, Alameh MG, Tam YK, Mui BL, Omo-Lamai S, Zamora ME, Shuvaeva T, Arguiri E, Gong X, Brysgel TV, Tan AW, Woolfork AG, Weljie A, Thaiss CA, Myerson JW, Weissman D, Kasner SE, Parhiz H, Muzykantov VR, Brenner JS, Marcos-Contreras OA (2024) Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke. Mol Ther 32(5):1344\u20131358. https:\/\/doi.org\/10.1016\/j.ymthe.2024.03.004","journal-title":"Mol Ther"},{"issue":"9","key":"6338_CR20","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41582-021-00530-8","volume":"17","author":"VX Han","year":"2021","unstructured":"Han VX, Patel S, Jones HF, Dale RC (2021) Maternal immune activation and neuroinflammation in human neurodevelopmental disorders. Nat Rev Neurol 17(9):564\u2013579. https:\/\/doi.org\/10.1038\/s41582-021-00530-8","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"6338_CR21","doi-asserted-by":"publisher","first-page":"E427","DOI":"10.1002\/ajh.26330","volume":"96","author":"K Wudhikarn","year":"2021","unstructured":"Wudhikarn K, Bansal R, Khurana A, Hathcock MA, Braksick SA, Bennani NN, Paludo J, Villasboas JC, Wang Y, Johnston PB, Ansell SM, Lin Y (2021) Age defining immune effector cell associated neurotoxicity syndromes in aggressive large B cell lymphoma patients treated with axicabtagene ciloleucel. Am J Hematol 96(11):E427\u2013E430. https:\/\/doi.org\/10.1002\/ajh.26330","journal-title":"Am J Hematol"},{"issue":"5","key":"6338_CR22","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jtct.2024.02.019","volume":"30","author":"PC Johnson","year":"2024","unstructured":"Johnson PC, Neckermann I, Sadrzadeh H, Newcomb R, El-Jawahri AR, Frigault MJ (2024) Clinical Outcomes and Toxicity in Older Adults Receiving Chimeric Antigen Receptor T Cell Therapy. Transplant Cell Ther 30(5):490\u2013499. https:\/\/doi.org\/10.1016\/j.jtct.2024.02.019","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"6338_CR23","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.ccell.2023.04.016","volume":"41","author":"C Yan","year":"2023","unstructured":"Yan C, Zheng L, Jiang S, Yang H, Guo J, Jiang LY, Li T, Zhang H, Bai Y, Lou Y, Zhang Q, Liang T, Schamel W, Wang H, Yang W, Wang G, Zhu ZJ, Song BL, Xu C (2023) Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity. Cancer Cell 41(7):1276. https:\/\/doi.org\/10.1016\/j.ccell.2023.04.016","journal-title":"Cancer Cell"},{"issue":"7","key":"6338_CR24","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.ccell.2023.05.013","volume":"41","author":"AB Chaves-Filho","year":"2023","unstructured":"Chaves-Filho AB, Schulze A (2023) Cholesterol atlas of tumor microenvironment provides route to improved CAR-T therapy. Cancer Cell 41(7):1204\u20131206. https:\/\/doi.org\/10.1016\/j.ccell.2023.05.013","journal-title":"Cancer Cell"},{"key":"6338_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-020-00190-8","volume":"8","author":"M Du","year":"2020","unstructured":"Du M, Hari P, Hu Y, Mei H (2020) Biomarkers in individualized management of chimeric antigen receptor T cell therapy. Biomark Res 8:1\u201313. https:\/\/doi.org\/10.1186\/s40364-020-00190-8","journal-title":"Biomark Res"},{"issue":"3","key":"6338_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","volume":"17","author":"S Rafiq","year":"2020","unstructured":"Rafiq S, Hackett CS, Brentjens RJ (2020) Engineering strategies to overcome the current roadblocks in CAR T cell therapy. Nat Rev Clin Oncol 17(3):147\u2013167. https:\/\/doi.org\/10.1038\/s41571-019-0297-y","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"6338_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","volume":"15","author":"SS Neelapu","year":"2018","unstructured":"Neelapu SS, Tummala S, Kebriaei P, Wierda W, Gutierrez C, Locke FL, Komanduri KV, Lin Y, Jain N, Daver N, Westin J, Gulbis AM, Loghin ME, de Groot JF, Adkins S, Davis SE, Rezvani K, Hwu P, Shpall EJ (2018) Chimeric antigen receptor T-cell therapy - assessment and management of toxicities. Nat Rev Clin Oncol 15(1):47\u201362. https:\/\/doi.org\/10.1038\/nrclinonc.2017.148","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"6338_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13045-023-01409-5","volume":"16","author":"E Jabbour","year":"2023","unstructured":"Jabbour E, Short NJ, Jain N, Haddad FG, Welch MA, Ravandi F, Kantarjian H (2023) The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades. J Hematol Oncol 16(1):22. https:\/\/doi.org\/10.1186\/s13045-023-01409-5","journal-title":"J Hematol Oncol"},{"issue":"35","key":"6338_CR29","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1200\/JCO.21.01992","volume":"39","author":"BD Santomasso","year":"2021","unstructured":"Santomasso BD, Nastoupil LJ, Adkins S, Lacchetti C, Schneider BJ, Anadkat M, Atkins MB, Brassil KJ, Caterino JM, Chau I, Davies MJ, Ernstoff MS, Fecher L, Funchain P, Jaiyesimi I, Mammen JS, Naidoo J, Naing A, Phillips T, Porter LD, Reichner CA, Seigel C, Song JM, Spira A, Suarez-Almazor M, Swami U, Thompson JA, Vikas P, Wang Y, Weber JS, Bollin K, Ghosh M (2021) Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline. J Clin Oncol 39(35):3978\u20133992. https:\/\/doi.org\/10.1200\/JCO.21.01992","journal-title":"J Clin Oncol"},{"issue":"4","key":"6338_CR30","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ymthe.2018.02.001","volume":"26","author":"KC Pituch","year":"2018","unstructured":"Pituch KC, Miska J, Krenciute G, Panek WK, Li G, Rodriguez-Cruz T, Wu M, Han Y, Lesniak MS, Gottschalk S, Balyasnikova IV (2018) Adoptive Transfer of IL13Ralpha2-Specific Chimeric Antigen Receptor T Cells Creates a Pro-inflammatory Environment in Glioblastoma. Mol Ther 26(4):986\u2013995. https:\/\/doi.org\/10.1016\/j.ymthe.2018.02.001","journal-title":"Mol Ther"},{"issue":"21","key":"6338_CR31","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","volume":"143","author":"TM Powell-Wiley","year":"2021","unstructured":"Powell-Wiley TM, Poirier P, Burke LE, Despres JP, Gordon-Larsen P, Lavie CJ, Lear SA, Ndumele CE, Neeland IJ, Sanders P, St-Onge MP, Council AHA, on L, Cardiometabolic H, Council on C, Stroke N, Council on Clinical C, Council on E, Prevention, Stroke C, (2021) Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation 143(21):e984\u2013e1010. https:\/\/doi.org\/10.1161\/CIR.0000000000000973","journal-title":"Circulation"},{"key":"6338_CR32","doi-asserted-by":"publisher","first-page":"115135","DOI":"10.1016\/j.addr.2023.115135","volume":"203","author":"L Liu","year":"2023","unstructured":"Liu L, Yoon CW, Yuan Z, Guo T, Qu Y, He P, Yu X, Zhu Z, Limsakul P, Wang Y (2023) Cellular and molecular imaging of CAR-T cell-based immunotherapy. Adv Drug Deliv Rev 203:115135. https:\/\/doi.org\/10.1016\/j.addr.2023.115135","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"6338_CR33","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1111\/bcp.14281","volume":"86","author":"N Dasyam","year":"2020","unstructured":"Dasyam N, George P, Weinkove R (2020) Chimeric antigen receptor T-cell therapies: Optimising the dose. Br J Clin Pharmacol 86(9):1678\u20131689. https:\/\/doi.org\/10.1111\/bcp.14281","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"6338_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.6004\/jnccn.2022.0020","volume":"20","author":"JA Thompson","year":"2021","unstructured":"Thompson JA, Schneider BJ, Brahmer J, Achufusi A, Armand P, Berkenstock MK, Bhatia S, Budde LE, Chokshi S, Davies M, Elshoury A (2021) Management of immunotherapy-related toxicities, version 1. 2022, NCCN clinical practice guidelines in oncology. J Natl Comprehens Cancer Network 20(4):387\u2013405. https:\/\/doi.org\/10.6004\/jnccn.2022.0020","journal-title":"J Natl Comprehens Cancer Network"},{"issue":"1","key":"6338_CR35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41467-019-13880-1","volume":"11","author":"A Sheih","year":"2020","unstructured":"Sheih A, Voillet V, Hanafi LA, DeBerg HA, Yajima M, Hawkins R, Gersuk V, Riddell SR, Maloney DG, Wohlfahrt ME, Pande D, Enstrom MR, Kiem HP, Adair JE, Gottardo R, Linsley PS, Turtle CJ (2020) Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy. Nat Commun 11(1):219. https:\/\/doi.org\/10.1038\/s41467-019-13880-1","journal-title":"Nat Commun"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06338-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06338-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06338-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T06:10:11Z","timestamp":1745561411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06338-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["6338"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06338-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5731012\/v1","asserted-by":"object"}]},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"29 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}